Stem cell gene therapy study for aging adults
Part of Blood & lymphatic clinical trials.
This trial tests a new way to rebuild your blood stem cells to possibly slow down aging. It is for healthy adults aged 45 to 65 without serious illnesses or recent cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 65 years old.
- You do not have a serious chronic illness that is out of control (like advanced heart, liver, or kidney disease).
- You have not had cancer in the last 5 years.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You have not taken medications that weaken your immune system (like steroids, chemotherapy, or immunosuppressants) in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage trial testing a new type of treatment called mRNA therapy that helps your body make missing proteins. Researchers are enrolling healthy volunteers to understand how safe and well-tolerated this approach is.
This trial tests dietary supplements and other treatments aimed at slowing the effects of aging. It is looking for generally healthy adults who are not taking immune-altering medications or other conflicting therapies.
This trial collects your own blood-forming stem cells (special cells that make blood) to advance gene therapy treatments for genetic bone marrow failure syndromes. Researchers will use growth factors to mobilize these cells into your bloodstream, then collect them through a process called apheresis—similar to donating blood plasma.
This study tests whether a single dose of a special stem cell treatment (HeXell-2020) is safe for older adults with mild to moderate frailty. Researchers want to see if it can help improve strength and daily function without causing serious side effects.
This trial tests a new stem cell treatment (called RB-ADSCs) that is injected into the fluid around your brain. It aims to see if these cells can help slow down memory loss and thinking problems in people with mild to moderate Alzheimer's disease.
This study looks at using a “half-matched” stem cell transplant (haploidentical transplant) in adults around your age with acute leukemia or MDS. It may help people who cannot find a fully matched donor, but are still eligible for this type of transplant.
Hear when a new Aging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.